Výsledky vyhledávání - "Mimi, Tesfaye"

Healthcare resource use and reimbursement amount by site of care in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell (CAR-T) therapy – a retrospective cohort study using CMS 100% Medicare claims database

Autor: Hongbo, Yang, Vamsi, Bollu, Stephen, Lim, Mimi, Tesfaye, Anand A, Dalal, Angela, Lax, Sakshi, Sethi, Jing, Zhao

Publikováno v: Leukemia & Lymphoma. 64:339-348

Chimeric antigen receptor T-cell (CAR-T) infusion settings may impact healthcare resource use (HRU) and reimbursement amounts. Adults with diffuse large B-cell lymphoma receiving CAR-T therapy were identified from the Centers for MedicareMedicaid Ser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b2f5e6395641e59d8acac0a9b141791
https://doi.org/10.1080/10428194.2022.2147395

Zobrazit plný text záznamu

Healthcare resource use (HRU) by infusion setting of chimeric antigen receptor T-cell (CAR-T) in patients with relapsed and refractory (r/r) diffuse large B-cell lymphoma (DLBCL): A retrospective cohort study using CMS 100% Medicare database

Autor: Jing Zhao, Stephen Lim, Vamsi Bollu, Hongbo Yang, Qiufei Ma, Angela Lax, Mimi Tesfaye, Anand A. Dalal

Publikováno v: Journal of Clinical Oncology. 39:e19550-e19550

e19550 Background: Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are CAR-T therapies that were approved for r/r DLBCL in 2017 and 2018, respectively. While majority of the CAR-T infusions occur at inpatient (IP) setting in clinica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2ac3ca8b987b9c9ba100785364680df
https://doi.org/10.1200/jco.2021.39.15_suppl.e19550

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání